Fund Tracker
AAREYDRUGSNSE

Aarey Drugs & Pharmaceuticals Limited

₹99.55NSE close, 28 Sep 2026 · market cap ₹282 cr (close × shares outstanding), shown for scale
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 31 AMCsShares outstanding and close: NSE, 28 Sep 2026Delivery: NSE bhavcopy, 28 Sep 2026 · 120 days collectedDeals: NSE deal files, 28 Sep 2026SLBM: NSE, 28 Sep 2026 · 31 days collectedMTF: NSE, 25 Sep 2026 · 30 days collectedFlags: NSE, 28 Sep 2026FPI: Shareholding pattern as of 6 Aug 2026, filed 7 Sep 2026Pledge: Shareholding pattern as of 6 Aug 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
—
Aug 2026
FPI holding, % of equity
4.41%▼ −0.40 pp
as of 6 Aug 2026
Fund houses holding
0
0 entered, 0 exited · Aug 2026 · index funds left out
Promoter pledge
0.00%■ 0.00 pp
as of 6 Aug 2026

What changed

No tracked fund house held AAREYDRUGS in Aug 2026 (31 AMCs tracked).

FPIs held 4.41% of AAREYDRUGS (as of 6 Aug 2026), −0.40 pp vs 30 Jun 2026.

1 · Mutual funds

AMC portfolios, Aug 2026 · 31 AMCs tracked

2 · Other big holders

Named FPIs at 1% or more

as of 6 Aug 2026
4.41%▼ −0.40 pp vs 30 Jun 2026

FPI category I + II, % of total shares · 1 named at 1% or more

FPIs named at 1% or more on 6 Aug 2026: Elysian Wealth Fund 2.87%.

Shareholding pattern as of 6 Aug 2026, filed 7 Sep 2026Source: NSE shareholding pattern filings (XBRL), quarterly Report a wrong number

Promoter pledge

as of 6 Aug 2026
0.00%■ 0.00 pp vs 30 Jun 2026

of promoter holding · 0.00% of total shares

Promoters had pledged 0 of their 1.32 cr shares on 6 Aug 2026.

Shareholding pattern as of 6 Aug 2026Source: NSE shareholding pattern filings (XBRL), quarterly Report a wrong number

3 · Insider trades

Insider and promoter

29 Jun 2026 to 26 Sep 2026
No insider or promoter trade in AAREYDRUGS was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL) Report a wrong number

4 · Trading

Delivery

28 Sep 2026
64.8%▲ +5.1 pp vs 20-day average

20-day average 59.7% · percentile 57 of 120 days collected

64.8% of the shares traded on 28 Sep 2026 were delivered, against a 20-day average of 59.7%; that day sits at percentile 57 of 120 days collected. By month over 40 months (Aug 2021 to Aug 2026), 56.8% of shares traded were delivered; lowest month 41.2% (Oct 2022), highest 80.9% (Jan 2025).

NSE bhavcopy, 28 Sep 2026 · 120 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily Report a wrong number

Bulk and block deals

90 days to 28 Sep 2026
₹5.4 cr3 deals

Buy side ₹5.4 cr · sell side ₹0.00 cr · both sides as reported

Largest: VAYUMIND INNOVATIONS PRIVATE LIMITED bought 2.74 lakh shares at ₹88.97 on 28 Aug 2026, a bulk deal of ₹2.4 cr.

NSE deal files, 28 Sep 2026Source: NSE bulk.csv and block.csv, daily 3 deals →Report a wrong number

5 · Leverage

SLBM borrowing

28 Sep 2026
NSE listed no SLBS open position for AAREYDRUGS on any of the 31 days collected, 14 Aug 2026 to 28 Sep 2026. No SLBM trades in AAREYDRUGS on 28 Sep 2026.
NSE, 28 Sep 2026 · 31 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily Report a wrong number

MTF book

25 Sep 2026
NSE listed no margin trading position for AAREYDRUGS on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE margin trading disclosure (mrg_trading), daily Report a wrong number

6 · F&O ban and surveillance

Red flags

28 Sep 2026
Long-term ASM stage 1

AAREYDRUGS has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. On 28 Sep 2026 NSE listed AAREYDRUGS under long-term ASM stage 1. Pledge invocations are not collected yet.

NSE, 28 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily Report a wrong number